Binding Free Energy Analysis of Programmed Cell Death Protein PD1 to its Ligand PD-L1

被引：0
|
作者：
Pan, Peter C. [1 ]
Tafazzol, Alireza [2 ]
Zhang, Xianwei [3 ]
Duan, Yong [2 ]
机构：
[1] Univ Calif Davis, Dept Neurol, Davis, CA 95616 USA
[2] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA
[3] Univ Calif Davis, Biophys Program, Davis, CA USA
来源：
BIOPHYSICAL JOURNAL | 2019年 / 116卷 / 03期
关键词：
D O I：
10.1016/j.bpj.2018.11.2576
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
2362-Pos
引用
收藏
页码：477A / 477A
页数：1
相关论文
共 50 条
  • [21] PROGRAMMED CELL DEATH LIGAND 1 (PD-L1) PROTECTS AGAINST DEATH IN NEONATAL SEPSIS
    Wakeley, Michelle
    Chung, Chun-Shiang
    Ayala, Alfred
    SHOCK, 2020, 53 : 95 - 95
  • [22] Outcomes of Programmed Cell Death Protein 1 (PD-1) and Programmed Death-Ligand 1 (PD-L1) Inhibitor Therapy in HIV Patients with Advanced Cancer
    Bari, Shahla
    Muzaffar, Jameel
    Chan, Austin
    Jain, Sanjay R.
    Haider, Ahmad M.
    Curry, Marjorie Adams
    Hostler, Christopher J.
    JOURNAL OF ONCOLOGY, 2019, 2019
  • [23] Programmed cell death protein-1 (PD-1)/programmed death-ligand-1 (PD-L1) axis in hepatocellular carcinoma: prognostic and therapeutic perspectives
    T. Mocan
    Z. Sparchez
    R. Craciun
    C. N. Bora
    D. C. Leucuta
    Clinical and Translational Oncology, 2019, 21 : 702 - 712
  • [24] Programmed cell death protein-1 (PD-1)/programmed death-ligand-1 (PD-L1) axis in hepatocellular carcinoma: prognostic and therapeutic perspectives
    Mocan, T.
    Sparchez, Z.
    Craciun, R.
    Bora, C. N.
    Leucuta, D. C.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2019, 21 (06): : 702 - 712
  • [25] Gene expression of programmed cell death (PD-1) and its ligand, PD-L1, in primary epithelial ovarian cancer
    Talukdar, S.
    Cepela, J.
    Chang, Z.
    Zhang, Y.
    Grad, A.
    Mullany, S. A.
    Starr, T.
    Winterhoff, B.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 254 - 254
  • [26] Programmed Cell Death 1 (PD-1) and Its Ligand (PD-L1) in Common Cancers and Their Correlation with Molecular Cancer Type
    Gatalica, Zoran
    Snyder, Carrie
    Maney, Todd
    Ghazalpour, Anatole
    Holterman, Daniel A.
    Xiao, Nianqing
    Overberg, Peggy
    Rose, Inga
    Basu, Gargi D.
    Vranic, Semir
    Lynch, Henry T.
    Von Hoff, Daniel D.
    Hamid, Omid
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2014, 23 (12) : 2965 - 2970
  • [27] In vitro Interactions of Chicken Programmed Cell Death 1 (PD-1) and PD-1 Ligand-1 (PD-L1)
    Reddy, Vishwanatha R. A. P.
    Mwangi, William
    Sadigh, Yashar
    Nair, Venugopal
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2019, 9
  • [28] ANALYSIS OF PD1 AND PD-L1 EXPRESSION IN GLIOBLASTOMA
    Berghoff, A. S.
    Kiesel, B.
    Widhalm, G.
    Woehrer, A.
    Dieckmann, K.
    Filipits, M.
    Marosi, C.
    Hainfellner, J. A.
    Preusser, M.
    Wick, W.
    NEURO-ONCOLOGY, 2014, 16
  • [29] PROGRAMMED DEATH-1 (PD-1), PROGRAMMED DEATH-LIGAND 1 (PD-L1) EXPRESSION IN UTERINE CARCINOSARCOMAS
    Gulec, U. Kucukgoz
    Bagir, E.
    Paydas, S.
    Seydaoglu, G.
    Guzel, A. B.
    Vardar, M. A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1125 - 1125
  • [30] PROGRAMMED DEATH-1 (PD-1), PROGRAMMED DEATH-LIGAND 1 (PD-L1) EXPRESSION IN UTERINE CARCINOSARCOMAS
    Gulec, U. Kucukgoz
    Bagir, E.
    Paydas, S.
    Seydaoglu, G.
    Guzel, A. B.
    Vardar, M. A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 219 - 219
12345